These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17623573)

  • 21. Outcome after second-trimester amniocentesis and first-trimester chorionic villus sampling for prenatal diagnosis in multiple gestations.
    Enzensberger C; Pulvermacher C; Degenhardt J; Kawecki A; Germer U; Weichert J; Krapp M; Gembruch U; Axt-Fliedner R
    Ultraschall Med; 2014 Apr; 35(2):166-72. PubMed ID: 23696061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers.
    Muller F; Thibaud D; Poloce F; Gelineau MC; Bernard M; Brochet C; Millet C; Réal JY; Dommergues M
    Prenat Diagn; 2002 Nov; 22(11):1036-9. PubMed ID: 12424771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RETIRED: Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus.
    Davies G; Wilson RD; Désilets V; Reid GJ; Shaw D; Summers A; Wyatt P; Young D;
    J Obstet Gynaecol Can; 2003 Feb; 25(2):145-48, 149-52. PubMed ID: 12577132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RETIRED: Prenatal invasive procedures in women with hepatitis B, hepatitis C, and/or human immunodeficiency virus infections.
    Gagnon A; Davies G; Wilson RD;
    J Obstet Gynaecol Can; 2014 Jul; 36(7):648-653. PubMed ID: 25184985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RETIRED: The use of first trimester ultrasound.
    Demianczuk NN; Van Den Hof MC; Farquharson D; Lewthwaite B; Gagnon R; Morin L; Salem S; Skoll A;
    J Obstet Gynaecol Can; 2003 Oct; 25(10):864-75. PubMed ID: 14532956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive outcome following amniocentesis for genetic indications.
    Porreco RP; Young PE; Resnik R; Cousins L; Jones OW; Richards T; Kernahan C; Matson M
    Am J Obstet Gynecol; 1982 Jul; 143(6):653-60. PubMed ID: 7091237
    [No Abstract]   [Full Text] [Related]  

  • 27. Constriction of the umbilical cord as a cause of fetal demise following midtrimester amniocentesis.
    Robertson RD; Rubinstein LM; Wolfson WL; Lebherz TB; Blanchard JB; Crandall BF
    J Reprod Med; 1981 Jun; 26(6):325-7. PubMed ID: 7252953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20,460 cases.
    Kozlowski P; Knippel A; Stressig R
    Ultraschall Med; 2008 Apr; 29(2):165-72. PubMed ID: 17602371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstetrical Outcomes of Amniocentesis or Chorionic Villus Sampling in Dichorionic Twin Pregnancies.
    Kim MS; Moon MJ; Kang S; Jung SH; Chang SW; Ki HJ; Kim B; Ahn E
    J Korean Med Sci; 2019 May; 34(18):e142. PubMed ID: 31074255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
    Crandall BF; Kulch P; Tabsh K
    Prenat Diagn; 1994 Oct; 14(10):913-9. PubMed ID: 7534922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal loss after amniocentesis in a series of 5,780 procedures.
    Gaudry P; Grangé G; Lebbar A; Choiset A; Girard S; Goffinet F; Lewin F
    Fetal Diagn Ther; 2008; 23(3):217-21. PubMed ID: 18417981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Midtrimester genetic amniocentesis. A review of the fetal risks.
    O'Brien WF
    J Reprod Med; 1984 Jan; 29(1):59-63. PubMed ID: 6708022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-operator comparison of early and mid-second-trimester amniocentesis.
    Assel BG; Lewis SM; Dickerman LH; Park VM; Jassani MN
    Obstet Gynecol; 1992 Jun; 79(6):940-4. PubMed ID: 1579318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients.
    Blessed WB; Lacoste H; Welch RA
    Am J Obstet Gynecol; 2001 Jun; 184(7):1340-2; discussion 1342-4. PubMed ID: 11408850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RETIRED: Ultrasound evaluation of first trimester pregnancy complications.
    Morin L; Van den Hof MC;
    J Obstet Gynaecol Can; 2005 Jun; 27(6):581-91. PubMed ID: 16100636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sampling and fetal blood sampling.
    Enzensberger C; Pulvermacher C; Degenhardt J; Kawacki A; Germer U; Gembruch U; Krapp M; Weichert J; Axt-Fliedner R
    Ultraschall Med; 2012 Dec; 33(7):E75-E79. PubMed ID: 22623130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks of prophylactic anti-D immunoglobulin after second-trimester amniocentesis.
    Tabsh KM; Lebherz TB; Crandall BF
    Am J Obstet Gynecol; 1984 May; 149(2):225-6. PubMed ID: 6326576
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of transabdominal and transcervical CVS and amniocentesis: sampling success and risk.
    Smidt-Jensen S; Philip J
    Prenat Diagn; 1991 Aug; 11(8):529-37. PubMed ID: 1722576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal loss following second trimester amniocentesis. Who is at greater risk? How to counsel pregnant women?
    Theodora M; Antsaklis A; Antsaklis P; Blanas K; Daskalakis G; Sindos M; Mesogitis S; Papantoniou N
    J Matern Fetal Neonatal Med; 2016; 29(4):590-5. PubMed ID: 25747948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group.
    Lancet; 1998 Jan; 351(9098):242-7. PubMed ID: 9457093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.